LeonaBio, Inc. Additional Paid in Capital, Common Stock
LeonaBio, Inc. (LONA) had Additional Paid in Capital, Common Stock of $597.31 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2026-08-14
- 2026-06-30: Additional Paid in Capital, Common Stock $597.31M.
- 2026-03-31: Additional Paid in Capital, Common Stock $594.02M.
- 2025-12-31: Additional Paid in Capital, Common Stock $539.55M.
- 2025-09-30: Additional Paid in Capital, Common Stock $455.65M.
| Period end | Additional Paid in Capital, Common Stock | Additional Paid in Capital, Common Stock as first filed |
|---|---|---|
| 2026-06-30 | $597.31M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $594.02M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $539.55M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $455.65M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $454.24M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $452.62M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $450.99M 10-K · filed 2026-03-31 | $450.98M 10-K · filed 2025-02-27 |
| 2024-09-30 | $448.72M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $445.77M 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $442.42M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $439.74M 10-K · filed 2025-02-27 | |
| 2023-09-30 | $437.36M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $434.87M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $431.50M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $428.62M 10-K · filed 2024-02-22 | |
| 2022-09-30 | $426.12M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $423.70M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $420.30M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $417.36M 10-K · filed 2023-03-23 | |
| 2021-09-30 | $415.79M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $414.55M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $413.09M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $315.29M 10-K · filed 2022-03-28 | |
| 2020-09-30 | $292.80M 10-Q · filed 2020-11-12 | |
| 2019-12-31 | $1.36M 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |